<DOC>
	<DOCNO>NCT00004136</DOCNO>
	<brief_summary>RATIONALE : Heating tumor several degree body temperature may kill tumor cell . PURPOSE : Phase II trial study effectiveness heat therapy treat patient unresectable primary metastatic liver cancer .</brief_summary>
	<brief_title>Heat Therapy Treating Patients With Unresectable Primary Metastatic Liver Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy radiofrequency ablation patient primary metastatic liver cancer . II . Determine disease free survival , local recurrence rate treat lesion compare known recurrence rate hepatic cryoablation , overall survival patient population receive regimen . OUTLINE : Patients undergo laparoscopic open laparotomy surgical procedure identify unresectable tumor ultrasound . Tumors heat target temperature electrodes maximum 20 minute . To achieve 1 cm margin ablate tissue around lesion , multiple ablation course may perform , depend size lesion time required complete treatment . Patients may retreat tumor recur new disease appear . Patients follow 1 month , every 3 month first 2 year , every 6 month next 3 year , annually thereafter . PROJECTED ACCRUAL : A maximum 59 patient accrue study .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis unresectable malignant primary metastatic liver tumor Tumors deem unresectable base follow factor : 110 liver tumor Bilobar liver tumor Location 1 lesion near major intrahepatic vascular structure ( hepatic vein , portal vein , vena cava ) Severe cirrhosis preclude major liver resection No unresectable extrahepatic disease Prior failure therapeutic modality allow No moderate ascites No hepatic encephalopathy PATIENT CHARACTERISTICS : Age : Any age Performance status : Zubrod 01 Life expectancy : At least 3 month Hematopoietic : Not specify Hepatic : No severe liver dysfunction ( Child 's Class C ) Bilirubin great 3.0 mg/dL Albumin great 3.0 mg/dL PT great 50 % normal Renal : No renal dysfunction Creatinine le 2.0 mg/dL Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No alter mental status No active infection PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since prior chemotherapy Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>stage III childhood liver cancer</keyword>
	<keyword>stage IV childhood liver cancer</keyword>
	<keyword>recurrent childhood liver cancer</keyword>
	<keyword>localize unresectable adult primary liver cancer</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
	<keyword>liver metastasis</keyword>
</DOC>